Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
about
Gene therapy of inherited retinal degenerations: prospects and challengesVisual Cone Arrestin 4 Contributes to Visual Function and Cone Health.Potential of Small Molecule-Mediated Reprogramming of Rod Photoreceptors to Treat Retinitis PigmentosaFunctional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa.Rescue of photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin mutation.Expression of wild-type Rp1 protein in Rp1 knock-in mice rescues the retinal degeneration phenotypeGene therapy for PRPH2-associated ocular disease: challenges and prospectsVector platforms for gene therapy of inherited retinopathies.Knockdown of NBCe1 in vivo compromises the corneal endothelial pump.The domestic cat as a large animal model for characterization of disease and therapeutic intervention in hereditary retinal blindness.Recombinant AAV-mediated BEST1 transfer to the retinal pigment epithelium: analysis of serotype-dependent retinal effects.AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.Variables and strategies in development of therapeutic post-transcriptional gene silencing agentsRepair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.Arrestin 1 and Cone Arrestin 4 Have Unique Roles in Visual Function in an All-Cone Mouse Retina.microRNAs: a new emerging class of players for disease diagnostics and gene therapy.Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell DegenerationAdvances in gene therapy technologies to treat retinitis pigmentosa.The use of canine models of inherited retinal degeneration to test novel therapeutic approaches.Gene therapy in the Retinal Degeneration Slow model of retinitis pigmentosa.Gene therapy in animal models of autosomal dominant retinitis pigmentosaSmall-interfering RNAs (siRNAs) as a promising tool for ocular therapy.Targeting carbonic anhydrase IX activity and expression.Late-onset cone photoreceptor degeneration induced by R172W mutation in Rds and partial rescue by gene supplementation.RNA interference for apoptosis signal-regulating kinase-1 (ASK-1) rescues photoreceptor death in the rd1 mouse.Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice.Gene delivery of wild-type rhodopsin rescues retinal function in an autosomal dominant retinitis pigmentosa mouse model.Novel p.M96T variant of NRL and shRNA-based suppression and replacement of NRL mutants associated with autosomal dominant retinitis pigmentosa.In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degenerationAAV-mediated knockdown of peripherin-2 in vivo using miRNA-based hairpins.
P2860
Q27009261-5F9C4CB0-CB27-46E2-926C-9734AFAB21E2Q27334918-9AA4D3AF-8211-4434-8410-4045A90260A1Q28818084-F3C648ED-A419-416E-A9B3-6F39F453DA8DQ33713504-7F191D64-43C4-442A-9FF1-849A0BE26569Q33954730-083E5746-9F95-413F-8F95-C38957D9C9C3Q34395630-44D41444-F5B9-4CBB-A2BE-0C91FA47F7A9Q34400262-E8F680D5-FA11-4224-A4F2-8DAED6EE7EC1Q34561531-AF389F18-62C5-4FAC-A322-E0C7E4255FDCQ34735219-E06E0167-0DAA-4098-B70A-60B035885C58Q34961635-91447870-832F-469C-80DB-D7FA5E6CE588Q35021596-FEF0E762-F9DD-4E63-A9D5-52D25B851167Q35092388-B4A766E9-A6B1-49A1-A245-6A64128F3C81Q35110219-0FA5D03D-15F5-4766-B1DE-4B9B7A866930Q35594834-E20BE32A-69C4-4185-9190-9D24B49AA749Q36147481-95A7AF8F-E5B7-417D-96C7-888DE03E152BQ36347393-86604640-1B0F-4A93-85E7-01116E3B3F86Q37035388-9B7AA5BC-130C-47D7-8C3B-5D52A5E776D8Q37407667-12F11916-EFE0-4695-BE44-4D81152449C0Q37427526-119E35F6-885E-4592-A5EA-37C542409683Q37458980-2F9FB954-73BE-42E4-B8B7-8CDAB9664331Q37711208-45D6F959-2CD0-4959-B8D8-159F16BB9D77Q38053151-5D48CA0D-68DA-45F8-9DC8-CD64D7AF9500Q38128390-AA77FEBA-4A38-4831-9399-C32CF2FB0CF8Q38342634-4632C8A8-61BB-4932-92B4-4C5B7D29C1B0Q40147345-D55A3E40-18DE-45F1-B59F-A069D1B4C186Q41971433-6249C6DF-2A32-494D-9A28-24F9C9A7B248Q42003725-D7D2D127-05C3-45E9-AC25-21C316DC171FQ42094440-028C34F1-F673-4BA5-B705-65309FF13D21Q42428325-BFAC11A5-7EA4-4057-91C8-E4437A2FBD17Q42502439-B8D14A53-6771-4145-A0EF-6F67B6C80FB3Q43221778-C9B26594-844C-470F-B22A-9986CBC40167
P2860
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
@en
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
@nl
type
label
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
@en
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
@nl
prefLabel
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
@en
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
@nl
P2093
P2860
P1433
P1476
Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
@en
P2093
P2860
P304
P356
10.1016/J.VISRES.2006.11.026
P577
2007-02-12T00:00:00Z